港股异动 | 丽珠医药(1513.HK)高开3.08% 附属新冠抗原检测试剂国内获批上市

格隆汇4月14日丨丽珠医药(1513.HK)高开3.08%，报26.8港元，总市值251亿港元。该公司昨日公布，公司控股附属公司珠海丽珠试剂股份有限公司(以下简称"丽珠试剂")自主研发的新型冠状病毒(2019-nCoV)抗原检测试剂盒(乳胶法)获国家药品监督管理局批准注册上市。

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.